Singapore HSA registration DE0510686

Abbott Diagnostics Korea Bioline™ HCV

Singapore flagSingapore·CLASS D IVD·Abbott Diagnostics Korea Inc.·Registered May 06, 2025
Device classification
Device Class
CLASS D IVD
Medical Speciality Area
Immunology
Registration information
Registration Number
DE0510686
Registration Date
May 06, 2025
Retention Due Date
May 05, 2026
Product description
The Bioline™ HCV test is an in vitro immunochromatographic, rapid assay designed for the qualitative detection of antibodies specific to HCV, in human serum, plasma, venous whole blood or finger prick whole blood. The Bioline™ HCV test kit is intended only for professional use as the initial test, as an aid to diagnosis. Reactive specimens should be followed up with nucleic acid testing (NAT) for the detection of HCV RNA together with a HCV immunoblot testing to identify current HCV infection. This test may not be suitable for diagnosis of early infection or blood donation screening.
Product Owner
Short Name
Abbott Diagnostics Korea Inc.
Address
65, Borahagal-ro, Giheung-gu,, Yongin-si, Gyeonggi-do 17099, KOREA, REPUBLIC OF
Registrant
Address
3 FRASER STREET, DUO TOWER, #23-28, SINGAPORE 189352
Importer
Address
3 FRASER STREET, DUO TOWER, #23-28, SINGAPORE 189352 10 RAEBURN PARK, #01-33, SINGAPORE 088702
Model information
Model Name(s)
Bioline™ HCV
Model Identifier(s)
02FK10CE
About this record

Access comprehensive regulatory information for Abbott Diagnostics Korea Bioline™ HCV in the Singapore medical device market through Pure Global AI's free database. This CLASS D IVD medical device is registered under HSA registration number DE0510686 and owned by Abbott Diagnostics Korea Inc.. The device was registered on May 06, 2025.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free DatabasePowered by Pure Global AIHSA Official DataCLASS D IVD